bluebird bio Inc at Barclays Global Healthcare Conference Transcript
Good afternoon, everyone. My name is Gena Wang, I'm the Senior Care Biotech Analyst at Barclays. It is my great pleasure to introduce our next speaker, Jeff Walsh, Chief Financial and Strategy Officer from bluebird.
There's a mic live here. Okay, I got it. I'm going to do it sitting down because I got in very late last night, I am kind of tired after a day of one-on-one's here. So if you guys don't mind. By the way, I have a few slides and it's really to introduce you to where we are as a company right now. And it's a pretty exciting time for bluebird as we hopefully are on the cusp of becoming a commercial stage company. It doesn't mean we're not at development stage. It doesn't mean we're not at research stage. But it's the first entrée for bluebird into this world. So really excited to be here Gena, and I look forward to getting some of the questions, and I know you have as well and any that others have.
I will be making
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |